FDA Inspection 1227468 — Nipro Vascular Innovations Americas Inc
The FDA completed an inspection of Nipro Vascular Innovations Americas Inc on Jan 9, 2024 in Bedford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 9, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Bedford, MA (United States)
Additional details
Sponsor, Contract Research Organization